Development of live cell chips to monitor cell differentiation processes

Engineering in Life Sciences

Volumn 8, Issue 1, 2008, Pages 33-39

  Maercker, C ^a,b   Rogge, T ^c   Mathis, H ^d   Ridinger, H ^e,g   Bieback, K ^f  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b MANNHEIM UNIVERSITY OF APPLIED SCIENCES   (Germany)

^c KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^d FRAUNHOFER GESELLSCHAFT   (Germany)

^e German Genome Resource Center RZPD   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

Author keywords

Adult stem cells; Cell adhesion; Genomics; Live cell imaging

Indexed keywords

BIOMARKERS; ELECTRIC FIELDS; ELECTRODES; OPTICAL MICROSCOPY; PROTEINS; TISSUE ENGINEERING;

CELL DIFFERENTIATION PROCESSES; CELLULAR PHENOTYPES; STEM CELLS;

CELL CULTURE;

BIOLOGICAL MARKER; PROTEIN;

BIOMARKERS; CELL CULTURE; ELECTRIC FIELDS; ELECTRODES; OPTICAL MICROSCOPY; PROTEINS; TISSUE ENGINEERING;

ADHESION; BIOASSAY; BIOMARKER; DIFFERENTIATION; ELECTRIC FIELD; ELECTRODE; EXPERIMENTAL STUDY; GENOMICS; MORPHOLOGY; OPTIMIZATION; PHENOTYPE;

ADIPOSE TISSUE; ARTICLE; BIOCHIP; CELL ADHESION; CELL DENSITY; CELL DIFFERENTIATION; CELL GROWTH; CELL HOMING; CELL ISOLATION; CELL STIMULATION; CELL STRUCTURE; CELL TYPE; ELECTRIC FIELD; ELECTRODE; ENDOTHELIUM CELL; EQUIPMENT DESIGN; FIBROBLAST; GENOMICS; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMPEDANCE; IN VITRO STUDY; MATERIAL COATING; MESENCHYMAL STEM CELL; MICROSCOPY; PROCESS MONITORING; PROCESS OPTIMIZATION; PROTEIN DETERMINATION; PROTEIN TRANSPORT; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 41149170771     PISSN: 16180240     EISSN: 16182863     Source Type: Journal    
DOI: 10.1002/elsc.200720225     Document Type: Article

References (37)

1. A. M. Wobus, K. R. Boheler, Embryonic stem cells: prospects for developmental biology and cell therapy, Physiol Rev. 2005, 85 (2), 635-678.
2. A. Pansky, B. Roitzheim, E. Tobiasch, Differentiation potential of adult human mesenchymal stem cells, Clin. Lab. 2007, 53 (1-2), 81-84.
3. A. Abdollahi, P. Hahnfeldt, C. Maercker, H. J. Gröne, J. Debus, W. Ansorge et al., Endostatin's antiangiogenic signaling network, Mol. Cell 2004, 13, 1-20.
4. U. R. Goessler, P. Bugert, K. Bieback, H. Sadick, A. Baisch, K. Hormann et al., In vitro analysis of differential expression of collagens, integrins, and growth factors in cultured human chondrocytes, Otolaryngol. Head Neck Surg. 2006, 134 510-515.
5. C. Maercker, Protein arrays in functional genome research, Biosci. Reports 2005, 25, 57-69.
6. D. Nikoloff, J. C. Shim, M. Fairchild, N. Patten, B. A. Fijal, W. H. Koch et al., Association between CYP2D6 genotype and tardive dyskinesia in Korean schizophrenics, Pharmacogenomics J. 2002, 2 (6), 400-407.
7. U. Steidl, R. Kronenwett, U. P. Rohr, R. Fenk, S. Kliszewski, C. Maercker et al., Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cells, Blood 2002, 99, 2037-2044.
8. U. Steidl, S. Bork, S. Schaub, O. Selbach, J. Seres, M. Aivado et al., Primary human CD34+ hematopoietic stem and progenitor cells express functionally active receptors of neuromediators, Blood 2004, 104, 81-88.
9. R. Kronenwett, U. Butterweck, U. Steidl, S. Kliszewski, F. Neumann, S. Bork et al., Distinct molecular phenotype of malignant CD34 (+) hematopoietic stem and progenitor cells in chronic myelogenous leukemia, Oncogene 2005, 24, 5313-5324.
10. L. S. Lamb Jr., Hematopoietic cellular therapy: implications for the flow cytometry laboratory, Hematol. Oncol. Clin. North. Am. 2002, 16, 455-476.
11. M. Kucia, J. Ratajczak, R. Reca, A. Janowska-Wieczorek, M. Z. Ratajczak, Tissue-specific muscle, neural and liver stem/progenitor cells reside in the bone marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood during stress and tissue injury, Blood Cells Mol. Dis. 2004, 32, 52-57.
12. A. Peled, O. Kollet, T. Ponomaryov, I. Petit, S. Franitza, V. Grabovsky et al., The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34 (+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice, Blood 2000, 95 (11), 3289-3296.
13. J. Yamaguchi, K. F. Kusano, O. Masuo, A. Kawamoto, M. Silver, S. Murasawa et al., Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization, Circulation 2003, 107, 1322-1328.
14. M. Majka, A. Janowska-Wieczorek, J. Ratajczak, M. A. Kowalska, G. Vilaire, Z. K. Pan, Stromal-derived factor 1 and thrombopoietin regulate distinct aspects of human megakaryopoiesis, Blood 2000, 96 (13), 4142-4151.
15. B. R. Son, L. A. Marquez-Curtis, M. Kucia, M. Wysoczynski, A. R. Turner, J. Ratajczak et al., Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases, Stem Cells 2006, 24 (5), 1254-1264.
16. S. Kern, H. Eichler, J. Stoeve, H. Klüter, K. Bieback, Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue, Stem Cells 2006, 24, 1294-1301.
17. A. Kocaoemer, S. Kern, H. Klüter, K. Bieback, Human AB-serum as well as thrombin-activated platelet-rich-plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue, Stem Cells 2007, 25, 1270-1274.
18. M. C. Overton, K. J. Blumer, Use of fluorescence resonance energy transfer to analyze oligomerization of G-protein-coupled receptors expressed in yeast, Methods 2002, 27 (4), 324-332.
19. S. Gross, D. Piwnica-Worms, Molecular imaging strategies for drug discovery and development, Review, Curr. Opin. Chem. Biol. 2006, 10 (4), 334-342.
20. +]: basic practical considerations, Methods Mol. Biol. 2006, 312, 3-36.
21. H. Thielecke, T. Stieglitz, H. Beutel, T. Matthies, H. H. Ruf, J. U. Meyer, Fast and precise positioning of single cells on planar electrode substrates, IEEE Eng. Med. Biol. Mag. 1999, 18, 48-52.
22. H. Thielecke, A. Mack, A. Robitzki, Hiohybrid microarrays - lmpedimetric biosensors with 3D in vitro tissues for toxicological and biomedical screening, Fresenius 1. Anal. Chem. 2001, 369, 23-29.
23. E. Thedinga, A. Kob, H. Hoist, A. Keuer, S. Drechsler, R. Niendorf et al., Online monitoring of cell metabolism for studying pharmacodynamic effects, Toxicol. Appl. Pharmacol. 2007, 220, 33-44.
24. M. Schulze, S. Drechsler, A. Kob, R. Ehret, E. Thedinga, Dynamisches Monitoring des Zellstoffwechsels in der präklinischen Wirkstoffentwicklung Laborjournal 2006, 7, 10-14.
25. R. B. Clarke, Isolation and characterization of human mammary stem cells, Cell Prolif. 2005, 38 (6), 375-86.
26. E. A. Cavalcanti-Adam, A. Micoulet, J. Blummel, J. Auernheimer, H. Kessler, J. P. Spatz, Lateral spacing of integrin ligands influences cell spreading and focal adhesion assembly, Eur. J. Cell Biol. 2006, 85, 219-24.
27. S. J. Remington, Fluorescent proteins: maturation, photochemistry and photophysics, Curr. Opin. Struct. Biol. 2006, 16, 714-721.
28. G. Temple, P. Lamesch, S. Milstein, D. E. Hill, L. Wagner, T. Moore, M. Vidal, From genome to proteome: developing expression clone resources for the human genome, Hum. Mol. Genet. 2006, 15, R31-43.
29. A. Ehlers, I. Riemann, M. Stark, K. Konig, Multiphoton fluorescence lifetime imaging of human hair, Microsc. Res. Tech. 2007, 70, 154-161.
30. M. Mimeault, S. K. Batra, Functions of tumorigenic and migrating cancer progenitor cells in cancer progression and metastasis and their therapeutic implications, Cancer Metastasis Rev. 2007, 26, 203-214.
31. D. R. Marshak, D. E. Greenwalt, Differentiating primary human cells in rapid-throughput discovery applications, Methods Mol. Biol. 2007, 356, 121-128.
32. A. F. Hoffman, R. J. Garippa, A pharmaceutical company user's perspective on the potential of high content screening in drug discovery, Methods Mol. Biol. 2007, 356, 19-31.
33. R. Allan, M. Kass, C. Glover, H. Haddad, Cellular transplantation: future therapeutic options, Curr. Opin. Cardiol. 2007, 22, 104-110.
34. K. Hishikawa, T. Fujita, Stem cells and kidney disease, Hypertens. Res. 2006, 29, 745-749.
35. D. Thomas, P. Zaccone, A. Cooke, The role of regulatory T cell defects in Type I Diabetes and the potential of these cells for therapy, Rev. Diabet. Stud. 2005, 2 (1), 9-18.
36. W. G. Wierda, T. J. Kipps, M. J. Keating, Novel immunebased treatment strategies for chronic lymphocytic leukemia, J. Clin. Oncol. 2005, 23, 6325-32.
37. A. I. Teixeira, J. K. Duckworth, O. Hermanson, Getting the right stuff: controlling neural stem cell state and fate in vivo and in vitro with biomaterials, Cell Res. 2007, 17, 56-61.